Solventum (MEX:SOLV) EBIT per Share : MXN102.90 (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Solventum EBIT per Share?

Solventum's EBIT per Share for the three months ended in Dec. 2024 was MXN14.33. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was MXN102.90.

During the past 12 months, the average EBIT per Share Growth Rate of Solventum was -39.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was -18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Solventum's EBIT per Share or its related term are showing as below:

MEX:SOLV' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -18.2 Med: -6.2 Max: 5.8
Current: -18.2

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Solventum was 5.80% per year. The lowest was -18.20% per year. And the median was -6.20% per year.

MEX:SOLV's 3-Year EBIT Growth Rate is ranked worse than
76.16% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 6.2 vs MEX:SOLV: -18.20

Solventum's EBIT for the three months ended in Dec. 2024 was MXN2,503 Mil.

Solventum EBIT per Share Historical Data

The historical data trend for Solventum's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum EBIT per Share Chart

Solventum Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

164.71

223.20

191.01

163.85

116.71

Solventum Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial						38.43	35.36	22.17	31.02	14.33

Solventum EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Solventum's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	20271.74	/	173.700
=	116.71

Solventum's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	2502.684	/	174.600
=	14.33

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN102.90

Solventum (MEX:SOLV) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Solventum EBIT per Share Related Terms

Thank you for viewing the detailed overview of Solventum's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Solventum Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (MEX:SOLV) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SOLV:USA KB7:Germany

Address

2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144

Website

https://www.solventum.com/en-us/home

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.